No Photo Available

Last Update

2005-10-12T00:00:00.000Z

This profile was last updated on .

Is this you? Claim your profile.

Wrong Luca Paola?

Dr. Luca Dalla Paola

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Background Information

Employment History

Surgeon With the Diabetic Foot Unit

Abano Terme Hospital

Chief Diabetic Professor

Foot & Ankle Clinic

Web References (9 Total References)


Post-Approval

genetown.biospace.com [cached]

$reference.text


Oculus Innovative Sciences ...

www.fdanews.com [cached]

Oculus Innovative Sciences announced that Luca Dalla Paola, a surgeon with the diabetic foot unit of the Abano Terme Hospital in Italy, recently presented the results of a 218-patient controlled clinical study that assessed the safety and efficacy of Microcyn Technology in treating diabetic foot ulcers as compared to povidone iodine (10%) antiseptic, which is often used as the "standard care" in treatment of open wounds.


Infection Control Today - Results of a Clinical Study Evaluating Treatment of Diabetic Foot Ulcers Using Microcyn Technology Presented at Wound Management Conference

www.infectioncontroltoday.com [cached]

STUTTGART, Germany -- Oculus Innovative Sciences, Inc. announces that Dr. Luca Dalla Paola, a surgeon with the diabetic foot unit of the Abano Terme Hospital in Italy, recently presented the results of a 218-patient controlled clinical study that assessed the safety and efficacy of Microcyn technology in treating diabetic foot ulcers as compared to povidone iodine (10 percent) antiseptic, which is often used as the "standard care" in treatment of open wounds.


RESULTS OF CLINICAL STUDY EVALUATING TREATMENT OF DIABETIC FOOT ULCERS USING MICROCYN™ TECHNOLOGY PRESENTED AT STUTTGART2005

www.oculusis.com [cached]

STUTTGART, GERMANY-- (October 4, 2005)- Oculus Innovative Sciences, Inc. announced that Dr. Luca Dalla Paola, a surgeon with the diabetic foot unit of the Abano Terme Hospital in Italy, recently presented the results of a 218-patient controlled clinical study that assessed the safety and efficacy of Microcyn® Technology in treating diabetic foot ulcers as compared to povidone iodine (10%) antiseptic, which is often used as the "standard care" in treatment of open wounds.


STUTTGART, GERMANY-- (October 4, 2005)- ...

www.oculusis.com [cached]

STUTTGART, GERMANY-- (October 4, 2005)- Oculus Innovative Sciences, Inc. announced that Dr. Luca Dalla Paola, a surgeon with the diabetic foot unit of the Abano Terme Hospital in Italy, recently presented the results of a 218-patient controlled clinical study that assessed the safety and efficacy of Microcyn® Technology in treating diabetic foot ulcers as compared to povidone iodine (10%) antiseptic, which is often used as the "standard care" in treatment of open wounds.

Similar Profiles

Other People with this Name

Other people with the name Paola

Denise De Paola
Cassels Brock & Blackwell LLP

Domenick Paola
Regatta Riverview Residences

Massimo Di Paola
MDP consultancy

Guy Di Paola
Telstra Corporation Limited

Patti Paola
Senvion

City Directory Icon

Browse ZoomInfo's Business Contact Directory by City

People Directory Icon

Browse ZoomInfo's
Business People Directory

Company Directory Icon

Browse ZoomInfo's
Advanced Company Directory